ATRA stock forecast
Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the March 7, 2024 when the stock price was at 0.70$.
In the short term (2weeks), ATRA's stock price should underperform the market by -1.75%. During that period the price should oscillate between -36.05% and +30.23%.
In the medium term (3months), ATRA's stock price should outperform the market by 0.15%. During that period the price should oscillate between -86.17% and +80.20%.
Get email alertsCreate a solid portfolio with ATRA
About Atara Biotherapeutics Inc
we launched atara biotherapeutics in august 2012 to help patients combat cancer, kidney disease and other illnesses. our research is based on groundbreaking discoveries regarding the ability of activin, myostatin and other growth factors to change the course of disease progression. our goal is to help patients such as atara ciechanover, our company’s namesake, who suffered from cancer before passing away in 2012. we aim to empower patients to fight their illnesses with better treatment options. atara biotherapeutics is developing several innovative product candidates, including pinta 745, stm 434 and ata 842, and is collaborating with memorial sloan kettering cancer center (msk) in the development of three t-cell product candidates: epstein-barr virus (ebv)-targeted cytotoxic t lymphocytes (ctls), cytomegalovirus (cmv)-targeted ctls, and wilms tumor 1 (wt1)-targeted ctls. each product candidate is designed to address the underlying mechanisms of disease to treat conditions which have
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.88$ per share.
The book value per share is 9.98$
Three months stock forecastMarch 7, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -291M | - | -144M | -2.88 | - | - | 101M | 9.98 | - | - | - |